Asia-Pacific monoclonal antibodies market is estimated to grow at a CAGR of 8.9% during the forecast period. Rising cancer incidences is the major factor in accelerating market growth. As per the World Health Organization (WHO), there were 4.3 million new cancer incidences reported in the country. Of these, lung (18.1%), colorectum (12.2%), stomach (10.6%), liver (9.2%), breast (8.6%), and other cancers (41.4%) of all new cancer cases in the country. Rising awareness regarding early detection of cancer has been witnessed in the country, which is supporting the increasing demand for novel cancer therapies. Monoclonal antibodies are laboratory-engineered molecules designed to attack particular features that are found on cancer cells. These antibodies are designed to discover specific proteins on cancer cells that are associated with the growth of those cells. These therapies may also be utilized to deliver radiation or chemotherapy directly to cancer cells. Monoclonal antibody drugs can function in several ways, including blocking cell growth and immune system inhibitors, flagging cancer cells, delivering chemotherapy and radiation treatment, directly attacking cancer cells, and others.
To Request a Sample of our Report on Asia-Pacific Monoclonal Antibodies Market: https://www.omrglobal.com/request-sample/asia-pacific-monoclonal-antibodies-market
Asia-Pacific Monoclonal Antibodies Market Segmentation
By Source
- Murine
- Chimeric
- Human
- Humanized
By Application
- Cancer
- Infectious Diseases
- Auto-Immune Diseases
- Inflammatory Diseases
- Others
A full Report of Asia-Pacific Monoclonal Antibodies Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-monoclonal-antibodies-market
Asia-Pacific Monoclonal Antibodies Market– Segment by Country
- China
- Japan
- India
Rest of Asia-Pacific
Company Profiles
- Amgen Inc.
- Anhui Anke Biotechnology (Group) Co., Ltd.
- Biocon Ltd.
- Chugai Pharmaceutical Co., Ltd.
- Daiichi Sankyo Company, Ltd.
- Reddy’s Laboratories, Inc.
- GenorBioPharma Co., Ltd.
- Lupin Ltd.
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Takeda Pharmaceutical Co., Ltd.
- Zhejiang Hisun Pharmaceutical Co., Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-monoclonal-antibodies-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
